loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r2_cep_1994_021___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SANOFI CHIMIE Gentilly FR (1)

    filter

    01 Ketoprofen (1)

    filter

    01 France (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    SANOFI CHIMIE Gentilly FR

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ketoprofen

    PDF Supplier PDF
    URL Supplier Web Content
    R2-CEP 1994-021 - Rev 03
    Withdrawn by Holder
    Chemical
    2010-05-06
    2019-03-12
    922
    Sanofi Company Banner

    Iran Expo

    Not Confirmed

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R2-CEP 1994-021 - Rev 03 of Sanofi Chimie Gentilly Fr

    Looking for Certificates of Suitability (CEPs) for R2-CEP 1994-021 - Rev 03 of Sanofi Chimie Gentilly Fr 1

    20

    Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    One of their significant offerings is Ketoprofen, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R2-CEP 1994-021 - Rev 03

    This Chemical Type CEP, issued on May 06, 2010, remains in force until March 12, 2019, ensuring its reliability within the pharmaceutical industry.

    Substance Number 922 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY